Literature DB >> 29699987

Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.

Yue He1, Chaokui Wang1, Guannan Su1, Bolin Deng1, Zi Ye1, Yang Huang1, Gangxiang Yuan1, Kijlstra Aize2, Hong Li3, Peizeng Yang3.   

Abstract

PURPOSE: A20 is a ubiquitously expressed and inducible cytosolic protein, which plays an important role in the negative regulation of inflammation and immunity. In this study, we investigated the role of A20 in Behcet's disease (BD) and Vogt-Koyanagi-Harada (VKH) disease.
METHODS: The levels of A20 in peripheral blood mononuclear cells (PBMCs) and dendritic cells (DCs) were detected in BD patients with active and inactive uveitis, VKH patients with active and inactive uveitis, and normal subjects, respectively, by real-time PCR. The effect of A20 silencing was performed by transduction of DCs with adenovirus containing an A20 shRNA vector. The effect of A20 silencing on the maturation of DCs was measured by flow cytometry. The effect of A20 silencing of DCs on cytokine production by DCs and CD4+ T cells was analysed by ELISA. The phosphorylation levels of JNK, p38 and ERK1/2 were detected by flow cytometry.
RESULTS: The expression of A20 was markedly decreased in PBMCs and DCs obtained from BD patients with active uveitis, but not in patients with VKH disease as compared with normal controls. Silencing of A20 significantly increased the levels of interleukin (IL)-1β and IL-6 and suppressed the expression of the anti-inflammatory cytokines IL-10 and IL-27. Downregulation of A20 also led to an increase in IL-17 production by CD4+ T cells. However, downregulation of A20 in DCs did not have an effect on cell surface markers such as CD40, CD80, CD83, CD86 and HLA-DR. Silencing of A20 caused an increased expression of phospho-JNK and phospho-MAPK p38 but not phospho-ERK1/2.
CONCLUSIONS: This study showed that the expression of A20 was decreased in BD patients with active uveitis but not in VKH disease. Decreased expression of A20 may lead to an enhanced activation of proinflammatory Th17 cells, causing a reactivation of BD. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  A20; Behcet’s disease; TNFAIP3; VKH disease; adenovirus; dendritic cells

Mesh:

Substances:

Year:  2018        PMID: 29699987     DOI: 10.1136/bjophthalmol-2017-311707

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Decreased microRNA-155 in Behcet's disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production.

Authors:  Liang Liang; Qingyun Zhou; Lujia Feng
Journal:  Arthritis Res Ther       Date:  2021-05-06       Impact factor: 5.156

2.  Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.

Authors:  Tarek R Elhamaky
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

3.  Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.

Authors:  Yanyun Jiang; Wenming Wang; Xiaofeng Zheng; Hongzhong Jin
Journal:  J Immunol Res       Date:  2020-03-21       Impact factor: 4.818

4.  A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells.

Authors:  Jianping Hu; Shenglan Yi; Chaokui Wang; Yiting Zhang; Jihong Tang; Xinyue Huang; Lu Yang; Jinglu Yang; Hong Li
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.